In a press release last month, the Plasma Protein Therapeutics Association (PPTA) said it believes the Internal Revenue Services' issuance of temporary and proposed regulations implementing the annual pharmaceutical fee undermines patients with rare diseases and fails to take into account concerns e... [More]

The Plasma Protein Therapeutics Association (PPTA) encouraged the Centers for Medicare and Medicaid Services (CMS) to improve drug reimbursement under the Hospital Outpatient Perspective Payment System. [More]

Treating hemophilia patients can costs hundreds of thousands of dollars annually. Clearly, providers, patients, manufacturers, case managers and insurers are impacted by reimbursement. [More]

Insurance is somewhat like a layer cake. The more layers a cake has, the more expensive the event the cake is intended for. The more layers or tiers, an insurance policy has, the more expensive the copay. [More]